Table 3.
Top aberrantly expressed RBPs in tumor
Number of tissues with aberrant expression | RBPS |
---|---|
4 | FUBP1, NCBP2, DKC1*, NONO*, EIF3S9* |
3 | CPSF6*, FXR1, PTBP1, STRBP, SYNJ2, SIAHBP1, RPL18, CSTF2, MRPL23, PNPT1, MARS, GARS, DSRAD, ANKRD17, LA*, C20orf119*, HNRPUL1*, NOL8*, NPM1*, PAIAP1*, RBM28*, RO60*, TACC1** |
2 | SNRPA, RBM8A, SLBP, RBM35A, RPS5*, RTCD1, HNRPG, RPL7, RBM14, FUS, RBM26, FUBP2, TRBP2, PPIE, CSTF3, RBM9, PSMA1, AKAP1, APOBEC1, NUFIP1, PABP4, RBM10, EIF3S4, TUT1, TIA1, RBM25**, IREB1**, NKRF |
The results obtained for each tumor type by the combined SAGE and microarray analyses were pulled together to determine RBPs that are aberrantly expressed in multiple tumor types. The genes labeled with *were determined to be upregulated in three different types of brain tumors and the genes labeled with **were determined to be downregulated in tumor samples.